![Alexander Dobbin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Alexander Dobbin is currently Head-Investor Relations at GRAIL, Inc. Formerly, Mr. Dobbin was Investor Relations Contact at Theravance Biopharma, Inc. from 2016 to 2019.
Postes actifs de Alexander Dobbin
| Sociétés | Poste | Début |
|---|---|---|
| GRAIL, INC. | Investor Relations Contact | - |
Anciens postes connus de Alexander Dobbin
| Sociétés | Poste | Fin |
|---|---|---|
| THERAVANCE BIOPHARMA, INC. | Investor Relations Contact | 01/04/2019 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Theravance Biopharma, Inc.
 Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
GRAIL, Inc.
 GRAIL, Inc. Medical SpecialtiesHealth Technology Manufactures cancer detection test kits and provides related services | Health Technology |
